陈元平

目的：分析PD-1抑制剂联合放化疗的应用价值。方法：选取2023年1月-2022年12月60例初治局部晚期宫颈癌患者，随机抽样法分组。对照组采用同步放化疗方案，观察组采用PD-1抑制剂联合同步放化疗方案。比较两组近远期疗效以及不良反应发生率的差异。结果：观察组近期疗效高于对照组，2年内复发率低于对照组，无进展生存期长于对照组，差异有意义（P＜0.05）；两组不良反应发生率差异无意义（P＞0.05）。结论：PD-1抑制剂联合放化疗可提高局部控制率，且不会增加不良反应发生率，可推广使用。

PD-1抑制剂；放化疗；宫颈癌

[1] 张亚慧,张荣,贾素红,等.同步放化疗并行免疫维持治疗在晚期宫颈癌患者中的潜在作用分析[J].中国计划生育和妇产科,2024,16(6):103-108. [2] 韩凤,李妮.同步热放化疗对晚期宫颈癌患者肿瘤标志物及 miR-21、miR-130 表达的影响[J].临床医学研究与实践,2024,9(20):59-63. [3] WANG,MANDI,PERUCHO,JOSE A.U.,VARDHANABHUTI,VARUT,et al.Radiomic Features of T2-weighted Imaging and Diffusion Kurtosis Imaging in Differentiating Clinicopathological Characteristics of Cervical Carcinoma[J].Academic radiology,2022,29(8):1133-1140. [4] GULER,OZAN CEM,ONAL,CEM.Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive(chemo-)radiotherapy:a systematic review and meta-analysis.In regard to De Virgilio et al[J].Journal of Cancer Research and Clinical Oncology,2022,148(9):2567-2568. [5] 徐月,田永巍,李宁.PD-1/PD-L1 抑制剂联合化疗对晚期宫颈癌的疗效及预后分析[J].实用癌症杂志,2024,39(7):1167-1170. [6] 刘超霞,冉晓敏,张克强,等.淋巴结转移的局部晚期宫颈癌行 PD-1 抑制剂联合同步放化疗的疗效及安全性研究[J].中国肿瘤临床,2023,50(8):418-422. [7] TOMALCZYK,ADAM,TOMASIK,BARTLOMIEJ,FIJUTH,JACEK,et al.Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions[J].Archives of gynecology and obstetrics.,2022,305(4):955-961. [8] 王翠,李亚玲.PD-1 抑制剂联合全身化疗治疗复发转移性宫颈癌的临床效果观察[J].临床误诊误治,2024,37(2):76-81. [9] 邵莎莎,曹丽艳,王光霞,等.抗 PD-1/PD-L1 免疫疗法联合同步放化疗治疗局部晚期宫颈癌的临床效果[J].中国医师杂志,2022,24(6):916-921. [10] SANTER,MATTHIAS,ZELGER,PHILIPP,SCHMUTZHARD,JOACHIM,et al.The Neck-Persistency-Net:a three-dimensional,convolution,deep neural network aids in distinguishing vital from non-vital persistent cervical lymph nodes in advanced head and neck squamous cell carcinoma after primary concurrent radiochemotherapy[J].European archives of oto-rhino-laryngology:Official journal of the European Federation of Oto-Rhino-Laryngological Societies(EUFOS),2024,281(11):5971-5982.

点击下载PDF